[1]周 鑫,孙晓莹,贾礼伊,等.中药单体川芎嗪在疾病治疗中的应用与机制研究进展[J].陕西中医,2022,(4):541-544.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.034]
　ZHOU Xin,SUN Xiaoying,JIA Liyi,et al.Research progress on application and mechanism of traditional Chinese medicine tetramethylpyrazine in disease treatment[J].,2022,(4):541-544.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.034]
点击复制

中药单体川芎嗪在疾病治疗中的应用与机制研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年4期
页码:
541-544
栏目:
综 述
出版日期:
2022-04-05

文章信息/Info

Title:
Research progress on application and mechanism of traditional Chinese medicine tetramethylpyrazine in disease treatment
作者:
周 鑫1; 孙晓莹2; 贾礼伊2; 郭 蒙2; 靳 洁2;  王引弟2; 黄 领2; 李奕衡3; 何钟竞3; 曹慧玲1; 2; 3
(1.西安医学院基础与转化医学研究所 陕西省缺血性心血管疾病重点实验室,陕西 西安 710021; 2.陕西中医药大学药学院,陕西 咸阳 712046; 3.西北大学生命科学学院,陕西 西安 710069)
Author(s):
ZHOU Xin; SUN Xiaoying; JIA Liyi;  GUO Meng;  JIN Jie;  WANG Yindi;  HUANG Ling;  LI Yiheng; HE Zhongjing;  CAO Huiling
(Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases, Institute of Basic & Translational Medicine, Xi'an Medical University, Xi'an 710021,China)
关键词:
川芎嗪;  心血管疾病;  脑疾病;  肾损伤;  肿瘤
Keywords:
Ligustrazine;  Cardiovascular disease;  Brain disease;  Kidney injury;  Tumor
分类号:
R 285
DOI:
DOI:10.3969/j.issn.1000-7369.2022.04.034
文献标志码:
A
摘要:
川芎嗪又称四甲基吡嗪,是提取自伞形科藁本属植物川芎根茎的一种中药单体成分,属于酰胺类生物碱。川芎嗪除了具有传统的活血祛瘀、抑制血小板聚集、扩张血管、改善血液循环、缓解疼痛等作用外,随着研究的不断深入,发现川芎嗪还具有心脑血管疾病预防与治疗、多器官如心脏、脑组织和肾脏等的缺血再灌注损伤修复、血管内皮保护、肿瘤抑制、哮喘病人气道重塑、钙超载抑制和免疫调节等作用。现从川芎嗪在心血管疾病、脑疾病、肾损伤、肿瘤等疾病中的应用,对近几年川芎嗪最新研究进展进行综述,以期为川芎嗪的临床应用提供参考。
Abstract:
Ligustrazine also known as tetramethylpyrazine(TMPZ),is a kind of monomer component of traditional Chinese medicine extracted from the rhizome of Ligusticum chuanxiong hort,which belongs to amide alkaloids.Ligustrazine has the classic functions of promoting blood circulation and removing blood stasis, inhibiting platelet aggregation,dilating blood vessels,improving blood circulation,and relieving pain.In addition, with the deepening of research,it was found that ligustrazine also has the functions of prevention and treatment of cardiovascular and cerebrovascular diseases,repair of ischemia-reperfusion injury of multiple organs such as heart,brain tissue and kidney,vascular endothelial protection,tumor inhibition,airway remodeling,calcium overload inhibition and immune regulation in asthma patients.This article will review the latest research progress of ligustrazine in recent years from the application of ligustrazine in cardiovascular disease,brain disease, kidney injury,tumor and other diseases,in order to provide reference for the clinical application of ligustrazine.

参考文献/References:

[1] 徐 浩.川芎嗪心血管药理与钙拮抗作用[J].中国中西医结合杂志, 2003,23(5):376-377.
[2] 邢晓莹,刘 毅,乔 羽,等.山西老陈醋陈酿过程中功能成分的变化研究[J].中国调味品,2021,46(8):52-56.
[3] Guo M,Liu Y,Shi D.Cardiovascular actions and therapeutic potential of tetramethylpyrazine:Roles and Mechanisms[J]. Biomed Res Int,2016,2016:2430329.
[4] 董小莉,马立宁,王 苗.川芎嗪对冠心病大鼠的血管保护作用研究[J].中国医药,2021,16(3):340-344.
[5] 陈乘波,陈天宝,许友榜.川芎嗪通过JAK2/STAT3信号通路调节线粒体自噬减轻心肌缺血再灌注损伤的机制研究[J].中国免疫学杂志,2021,37(7):819-823.
[6] 段亚妮,张 军.丹参川芎嗪辅助治疗不稳定型心绞痛的临床效果及对炎症因子水平的影响[J].临床医学研究与实践,2021,6(9):136-138,141.
[7] 陈世华,付绪华,袁丹桂,等.川芎嗪对感染性休克大鼠脑组织PI3K/AKT信号通路及热休克蛋白70的影响[J].中西医结合心脑血管病杂志,2021,19(12):2010-2015.
[8] 殷翠儿,庞伟冰.川芎嗪抗癫痫作用及其机制研究进展[J].辽宁中医药大学学报,2022,24(1):121-125.
[9] 魏亚琪.川芎嗪联合血栓通治疗缺血性脑卒中的临床疗效[J].临床合理用药杂志,2021,14(18):114-116.
[10] 杨梦琳,周小青,伍大华,等.基于网络药理学的丹参-川芎药对治疗阿尔茨海默病的作用机制分析[J].天然产物研究与开发,2021,33(8):1382-1390.
[11] Mehrotra P,Sturek M,Neyra JA,et al.Calcium channel Orai1 promotes lymphocyte IL-17 expression and progressive kidney injury[J].J Clin Invest,2019,129:4951-4961.
[12] Kar F,Hacioglu C,Senturk H,et al.The role of oxidative stress,renal inflammation,and apoptosis in post ischemic reperfusion injury of kidney tissue:The protective effect of dose-dependent boric acid administration[J].Biol Trace Elem Res,2019,195:150-158.
[13] Sun W,Li A,Wang Z,et al.Tetramethylpyrazine alleviates acute kidney injury by inhibiting NLRP3/HIF1α and apoptosis[J].Mol Med Rep,2020,22(4):2655-2664.
[14] Jiang G,Xin R,Yuan W,et al.Ligustrazine ameliorates acute kidney injury through downregulation of NOD2 mediated inflammation[J].Int J Mol Med,2020,45(3):731-742.
[15] 李万海,董宇航,施 超,等.川芎嗪呋咱拼合物保护肾缺血再灌注损伤模型小鼠的作用及机制[J].中国组织工程研究,2021,26(2):213-218.
[16] 王玉洁,曹 灵,胡承刚,等.川芎嗪对膜性肾病的治疗作用及对内质网应激的拮抗[J].中药材,2021,44(5):1211-1216.
[17] Pan J,Shang JF,Jiang GQ,et al.Ligustrazine induces apoptosis of breast cancer cells in vitro and in vivo[J].J Cancer Res Ther,2015,11(2):454-458.
[18] Shen J,Zeng L,Pan L,et al.Tetramethylpyrazine regulates breast cancer cell viability,migration,invasion and apoptosis by affecting the activity of AKT and Caspase-3[J].Oncol Lett,2018,15(4):4557-4563.
[19] Yin J,Yu C,Yang Z,et al.Tetramethylpyrazine inhibits migration of SKOV3 human ovarian carcinoma cells and decreases the expression of interleukin-8 via the ERK1/2,p38 and AP-1 signaling pathways[J].Oncol Rep,2011,26(3):671-679.
[20] Chen L,Lu Y,Wu JM,et al.Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by vascular endothelial growth factor[J].Biochem Biophys Res Commun,2009,386(2):374-379.
[21] Bian Y,Yang L,Sheng W,et al.Ligustrazine induces the colorectal cancer cells apoptosis via p53-dependent mitochondrial pathway and cell cycle arrest at the G0/G1 phase[J].Ann Palliat Med,2021,10(2):1578-1588.
[22] Chen Z,Pan X,Georgakilas AG,et al.Tetramethylpyrazine protects cerebral neurocytes and inhibits glioma by down regulating chemokine receptor CXCR4 expression[J].Cancer Lett,2013,336(2):281-289.
[23] 庞皓玥,胡凯文,孙满强,等.川芎嗪联合顺铂通过调控PI3K/AKT/mTOR通路对人肺癌A549细胞侵袭能力及线粒体功能的影响[J].肿瘤预防与治疗,2021,34(3):199-206.
[24] Cheng L,Ma H,Shao M,et al.Synthesis of folatechitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells[J].Mol Med Rep,2017,16(2):1101-1108.
[25] 王 楠,许 良,吴国明.川芎嗪对成纤维细胞增殖及TGF-β1和bFGF表达的影响[J].中国美容医学,2021,30(5):56-58.
[26] 肖 凯,杨 林,周江红,等.川芎嗪对肌肉骨骼疾患大鼠比目鱼肌钙离子通道及细胞凋亡的影响及机制[J].中国病理生理杂志,2021,37(3):512-517.
[27] 王会含,王永堂,苗建华,等.川芎嗪对人骨关节炎软骨细胞的影响及作用机制研究[J].中医正骨,2021,33(7):4-10,16.
[28] 丁 珍,于 菲,万经红.川芎嗪对支气管上皮细胞ORMDL3表达影响[J].青岛大学学报:医学版,2021,57(2):276-279.
[29] 张雅丽,王国海,孟祥波.川芎嗪减轻大鼠视网膜缺血-再灌注损伤的作用及机制探究[J].临床和实验医学杂志,2021,20(12):1245-1248.
[30] 汪燕红,张利丹,谢雁鸣,等.真实世界中使用丹参川芎嗪注射液临床应用特点及联合用药特征分析[J].中医药学报,2021,49(7):61-67.

相似文献/References:

[1]郑思敏,张少博,牛晓丽△,等.川芎嗪通过激活PKCα/Nrf2信号转导抑制七氟烷诱导的氧化损伤和血脑屏障破坏研究*[J].陕西中医,2020,(8):1025.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.004]
　ZHENG Simin,ZHANG Shaobo,NIU Xiaoli,et al.Ligustrazine inhibits sevoflurane-induced oxidative damage and blood-brain barrier disruption by activating PKCα/Nrf2 signaling[J].,2020,(4):1025.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.004]
[2]杨洛琦,谢连娣,周莉君.从藏象理论探析糖尿病心肌病[J].陕西中医,2022,(10):1423.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.024]
　YANG Luoqi,XIE Liandi,ZHOU Lijun.Treatment of the diabetic cardiomyopathy based on the Chinese medicine viscera manifestation theory[J].,2022,(4):1423.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.024]
[3]顾民华,顾 勇.川芎嗪通过miR-34a对氧化型低密度脂蛋白诱导的冠状动脉内皮细胞损伤的保护作用[J].陕西中医,2023,(9):1169.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.002]
　GU Minhua,GU Yong.Protective effect and mechanism of ligustrazine on coronary artery endothelial cell injury induced by oxidized low-density lipoprotein through miR-34a[J].,2023,(4):1169.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.002]
[4]姜春云,姜 泉,常 甜,等.基于“体脏合痹-瘀”辨治类风湿关节炎合并心血管疾病[J].陕西中医,2025,46(3):372.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.018]
　JIANG Chunyun,JIANG Quan,CHANG Tian,et al.Differentiation and treatment of rheumatoid arthritis combined with cardiovascular diseases based on body dysmorphia-stasis[J].,2025,46(4):372.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.018]

备注/Memo

备注/Memo:
基金项目:陕西省科技厅自然科学青年基金资助项目(2020JQ-885); 陕西省教育厅重点实验室项目(20JS138); 西安医学院博士基金资助项目(2020DOC28)
更新日期/Last Update: 2022-04-08